National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

HIV/AIDS
 Understanding
 Research
  Research Program
  Basic Research
  Epidemiology
  Prevention
   Research Areas
  Therapeutics
  Vaccines
  Clinical Research
  Advisory Groups and Committees
  Partners and Collaborators
  Funding Opportunities
  Scientific Meetings, Workshops and Events


HIV/AIDS

Prevention

NIAID is conducting and supporting research to develop new strategies to prevent the spread of HIV. These strategies include vaccines, topical microbicides, such as gels, creams and foams, that can be applied to the vagina or rectum prior to sexual intercourse, and providing antiretrovirals to people who are not infected with HIV but who are at high risk of acquiring HIV infection (called pre-exposure prophylaxis (PrEP)). NIAID is committed to finding scientifically proven HIV prevention strategies and methods that are acceptable for use by different patient populations around the world to combat the HIV/AIDS epidemic. To accelerate the identification and evaluation of new concepts, strategies, and products, NIAID partners with community advisory groups, scientific investigators, and other organizations.

Research-based prevention strategies have already contributed to the maintenance of low infection rates in a number of settings and to declining HIV epidemics in specific populations around the world. In resource-constrained countries, in particular, non-vaccine prevention strategies are important for reducing new infections where there is limited access to health care and antiretroviral drugs.

NIAID’s HIV/AIDS prevention research agenda is guided by the NIH Office of AIDS Research (OAR), the entity responsible for the overall scientific, budgetary, legislative, and policy elements of all AIDS research sponsored by NIH.  The major goals of NIAID's prevention research agenda include:

  • Develop and test promising biomedical and behavioral HIV prevention products and interventions in clinical trials
  • Integrate prevention research into the overall HIV/AIDS research agenda
  • Identify opportunities to integrate the planning of HIV prevention research with existing developing country infrastructures
  • Develop and implement effective ways to translate new knowledge into wider practice
  • Disseminate information about intervention strategies that can significantly reduce the incidence of new HIV infections

Additional Information

Highlights

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News

  • Highlights

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research—Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009—Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009—Sept. 25, 2009

    See Also

  • Division of AIDS
  • Vaccine Research Center
  • HIV/AIDS Publications
  • HIV/AIDS News Releases
  • Global Research, Africa
  • Selected NIAID Science Advances, 2007-2008 (PDF)
  • Vaccines
  • NIAID Funding News